Yanhong Deng

TL;DR: A drop in ctDNA level is an early marker of therapeutic efficacy and predicts prolonged survival in patients treated with immune checkpoint inhibitors for NSCLC.

TL;DR: The coronav virus‐19 disease (COVID‐19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 virus, is associated with significant morbidity and mortality attributable to pneumonia, acute respiratory distress syndrome, and multiorgan failure.

TL;DR: In this first prospective study of modified FOLFIRINOX in MPC and LAPC, decreased AEs are observed compared with historical control patients and the efficacy appears comparable with FOL FIRINOX, and support the continued use of F OLFIRinoX in this setting.

TL;DR: Patients with BBPS scores of 2 or 3 for all colon segments have adequate bowel preparation for the detection of adenomas larger than 5 mm and should return for screening or surveillance colonoscopy at standard guideline-recommended intervals.

TL;DR: It is suggested that the TRM subset of TILs may be the major target of ICP blockade and illustrate interlesional diversity of tissue-resident TCRs within individual metastases, which did not equilibrate between metastases and may differentially affect the outcome of immune therapy at each site.